In 1997, Carmeci and colleagues [6] cloned GPR30 from the breast cancer cell line MCF-7, further demonstrated by Revankar and colleagues [7] to be a membrane estrogen receptor belonging to the superfamily of receptors coupled to G proteins. Here, GPER1 is linked to breast carcinoma.